Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ultratech India is an active Indian pharmaceutical and life sciences company focused on development, manufacturing, and marketing of finished dosage forms, active pharmaceutical ingredients, and drug intermediates. The company has particular expertise in pulmonary drug delivery systems, including dry powder inhalers, pressurized metered dose inhalers, and nebulization solutions for anti-asthmatic therapies. It also operates API and intermediate manufacturing capabilities built around synthetic chemistry scale-up, and provides custom research and manufacturing services, contract manufacturing, and private labeling. In addition to respiratory products, Ultratech markets branded generics and related products across therapeutic categories such as cardiology, diabetology, gynecology, anti-infectives, oncology-supportive segments, nutraceuticals, and health supplements. The business appears to be a commercial-stage, revenue-generating unlisted public company headquartered in Navi Mumbai, India.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ultratech.